Obesity
Latest News
Weight Loss Interventions Improve Key Features of PCOS
“This is the first review to show a clinically significant association in improvement in menstrual frequency with weight loss interventions, an...
Latest News
Topiramate Plus Metformin Effective for Weight Loss in PCOS
Topiramate combined with metformin resulted in greater mean weight loss at 3 months and 6 months than placebo plus metformin.
Conference Coverage
Coming Soon: A New Disease Definition, ‘Clinical Obesity’
“I think it’ll help explain and move medicine as a whole in a direction to a greater understanding of obesity actually being a disease, how to...
Latest News
Can We Repurpose Obesity Drugs to Reverse Liver Disease?
A new retrospective observational study offers evidence that GLP-1 RAs may have a direct impact on MASLD,...
Conference Coverage
ATA: Updates on Risk, Diagnosis, and Treatment of Thyroid Cancer
Researchers compared medical records of adults with type 2 diabetes and moderate cardiovascular risk who were new users of GLP-1 receptor agonists...
Commentary
Lifestyle Medicine Trends to Keep an Eye On
“What we truly need is a patient-centered approach that restores health by addressing not just diagnoses but also the physical, emotional, and...
Conference Coverage
Weight Loss Surgery, Obesity Drugs Achieve Similar Results but Have Different Safety Profiles
Although all interventions were associated with reductions in percentage total weight loss compared with placebo, RYGB led to the greatest...
Opinion
Obesity: A Social Vulnerability
If we’re going to continue calling it a disease, we have done a pretty sloppy job of creating diagnostic criteria.
Feature
Should the Body Roundness Index Replace BMI?
Several studies have suggested that BRI could be a valuable tool for assessing health risks.
Conference Coverage
Know the Ins and Outs of Prescribing Obesity Medications in Pediatric Patients
Using obesity medications in youth is a new and evolving area of pediatrics and more education is needed.
Commentary
Cardiovascular Disease 2050: No, GLP-1s Won’t Save the Day
Harvard Medical School professor tells “where we will be in 2050” if prior trends remain the same.